Search results

Skip to results

Type

Type

Last updated

Last updated

Advice programme

Showing 1 to 2 of 2 results for voriconazole

  1. What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for treating suspected or confirmed COVID-19-associated pulmonary aspergillosis (CAPA), and the optimal treatment duration? When should treatment be started, stopped or modified?

    immunosuppression, and subgroups who have higher rates of COVID-19. I: voriconazole, isavuconazole, liposomal amphotericin B,...

    Research recommendation
    Published
    9 March 2022

  2. Fungitell for antifungal treatment stratification (MIB118)

    NICE has developed a medtech innovation briefing (MIB) on Fungitell for antifungal treatment stratification .

    Medtech innovation briefing
    Published
    31 August 2017